Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu-Hsien Yu

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|October 13, 2021
AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer PatientsPo-Chao Hsu, Tai-Kuang Chao, Yu-Ching Chou, et al.
World Journal of Gastroenterology|April 9, 2015
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinomaChih-Chi Kuo, Yu-Lueng Shih, Her-Young Su, et al.
International Journal of Environmental Research and Public Health|November 24, 2019
<i>Pyruvate Kinase M2</i> Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial CarcinomaYu-Ju Lai, Yu-Ching Chou, Yi-Jia Lin, et al.
Cancer Genetics and Cytogenetics|September 8, 2004
Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypesRui-Len Huang, Chung-Faye Chao, Dah-Ching Ding, et al.
Gynecologic Oncology|December 3, 2014
DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasiaHung-Cheng Lai, Yu-Chi Wang, Mu-Hsien Yu, et al.
Gynecologic Oncology|October 25, 2011
A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumorsHsu-Dong Sun, Hao Lin, Mei-Shan Jao, et al.
Cancers|April 12, 2022
Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort StudyCheng-Yang Chou, Wen-Fang Cheng, Min-Yu Chen, et al.
Journal of Gynecologic Oncology|June 29, 2017
Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) studyAn Jen Chiang, Min Yu Chen, Chia Sui Weng, et al.
International Journal of Molecular Sciences|October 26, 2018
Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome AnalysisCheng-Chang Chang, Kuo-Min Su, Kai-Hsi Lu, et al.
International Journal of Molecular Sciences|April 23, 2020
The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome AnalysisKuo-Min Su, Tzu-Wei Lin, Li-Chun Liu, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|October 13, 2021
AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer PatientsPo-Chao Hsu, Tai-Kuang Chao, Yu-Ching Chou, et al.
World Journal of Gastroenterology|April 9, 2015
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinomaChih-Chi Kuo, Yu-Lueng Shih, Her-Young Su, et al.
International Journal of Environmental Research and Public Health|November 24, 2019
<i>Pyruvate Kinase M2</i> Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial CarcinomaYu-Ju Lai, Yu-Ching Chou, Yi-Jia Lin, et al.
Cancer Genetics and Cytogenetics|September 8, 2004
Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypesRui-Len Huang, Chung-Faye Chao, Dah-Ching Ding, et al.
Gynecologic Oncology|December 3, 2014
DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasiaHung-Cheng Lai, Yu-Chi Wang, Mu-Hsien Yu, et al.
Gynecologic Oncology|October 25, 2011
A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumorsHsu-Dong Sun, Hao Lin, Mei-Shan Jao, et al.
Cancers|April 12, 2022
Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort StudyCheng-Yang Chou, Wen-Fang Cheng, Min-Yu Chen, et al.
Journal of Gynecologic Oncology|June 29, 2017
Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) studyAn Jen Chiang, Min Yu Chen, Chia Sui Weng, et al.
International Journal of Molecular Sciences|October 26, 2018
Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome AnalysisCheng-Chang Chang, Kuo-Min Su, Kai-Hsi Lu, et al.
International Journal of Molecular Sciences|April 23, 2020
The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome AnalysisKuo-Min Su, Tzu-Wei Lin, Li-Chun Liu, et al.
Pageof 11